semaglutide available in canada Health approves Wegovy® (semaglutide injection) to reduce the risk of non-fatal myocardial infarction Generic semaglutide to hit Canadian

Retatrutide vs Mounjaro Retatrutide extends the dual agonist model into triple agonism

If symptoms are severe or don't improve, contact your healthcare provider

In Phase 2 trials, female participants actually achieved slightly higher average weight loss than men at 25.3% versus 22.8% over 48 weeks

What is my long-term plan if I decide to discontinue GLP-1 therapy

To be clear, the pledges are being positioned as voluntary changes

Patients who may benefit include those with: Obesity or a high starting weight Difficulty managing blood sugar despite lifestyle changes Metabolic disorders that impact energy use and fat storage A history of limited success with other weight loss treatments That said, medications are not magic bullets